Safety and tolerability of targeted therapies for pulmonary hypertension in children.
about
Progress in the diagnosis and management of pulmonary hypertension in children.Sildenafil in pediatric pulmonary arterial hypertension.Sildenafil for the treatment of pulmonary hypertension in children.Development of a UPLC-MS/MS method for the quantification of sildenafil by DBS, and its use on pediatric pulmonary hypertension.
P2860
Safety and tolerability of targeted therapies for pulmonary hypertension in children.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Safety and tolerability of targeted therapies for pulmonary hypertension in children.
@en
Safety and tolerability of targeted therapies for pulmonary hypertension in children.
@nl
type
label
Safety and tolerability of targeted therapies for pulmonary hypertension in children.
@en
Safety and tolerability of targeted therapies for pulmonary hypertension in children.
@nl
prefLabel
Safety and tolerability of targeted therapies for pulmonary hypertension in children.
@en
Safety and tolerability of targeted therapies for pulmonary hypertension in children.
@nl
P2093
P2860
P1433
P1476
Safety and tolerability of targeted therapies for pulmonary hypertension in children.
@en
P2093
P2860
P2888
P304
P356
10.1007/S00246-013-0811-4
P577
2013-10-20T00:00:00Z